HOME › DRUGS › CAPMATINIB
ACTIVE SUBSTANCE / INN

CAPMATINIB

Brand name(s): Tabrecta
EMA LISTED
AUTHORISED
Carcinoma, Non-Small-Cell Lung
ACTIVE SUBSTANCE
Capmatinib
REGULATORS
EMA
SPONSORS / MAH
Novartis Europharm Limited
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
TabrectaNovartis Europharm LimitedAuthorised20/06/2022Carcinoma, Non-Small-Cell Lung

FULL INTELLIGENCE ON CAPMATINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →